Unlocking Opportunities in the Coronary Stents Market: 2025-2034 Forecast Report

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Coronary Stents Industry Market Size Be by 2025?
The dimension of the coronary stents market has seen a robust expansion in the past few years. It is projected to evolve from $11.06 billion in 2024 to an impressive $11.9 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.6%. This growth throughout the previous period pivots on an increased inclination for minimally invasive procedures, improving healthcare accessibility in burgeoning markets, escalating healthcare expenditure, the growth in percutaneous coronary interventions, and an upsurge in the population of cardiologists.

What's the Long-Term Growth Forecast for the Coronary Stents Market Size Through 2029?
The market size of coronary stents is anticipated to witness robust growth in the forthcoming years. It is forecasted to expand to $16.4 billion in 2029, maintaining a compound annual growth rate (CAGR) of 8.3%. The projected expansion can be traced back to several factors such as the uptick in the occurrence of cardiovascular diseases, the aging demographic, heightened awareness pertaining to cardiovascular health, beneficial government schemes and funding, and the increasing prevalence of lifestyle diseases. Standout trends during the forecast period encompass advancements in stent and imaging technology, strategic alliances and partnerships, the evolution of stent materials, and the technological assimilation with digital health.

View the full report here:
https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

What Are the Key Growth Drivers Fueling the Coronary Stents Market Expansion?
As cardiovascular diseases (CVDs) continue to rise, it is anticipated that this will stimulate growth in the coronary stent market. CVDs comprise a set of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, stroke, and hypertension. An aging population, obesity, diabetes, poor nutrition, sedentary lifestyles, and stress are key factors contributing to the increase of these diseases. Coronary stents, which help to open blocked or narrowed arteries, thus improving blood flow to the heart and reducing heart attack risk, become more necessary in the wake of these conditions. For instance, a forecast released in August 2022 by the non-profit medical association, the American College of Cardiology, predicted substantial increases in cardiovascular risk factors in the U.S. between 2025 and 2060. It projected that diabetes will grow by 39.3% to affect 55 million people, dyslipidemia will rise by 27.6% to affect 126 million, hypertension will escalate by 25.1% to involve 162 million, and obesity will increase by 18.3% to impact 126 million. The most significant increases in cardiovascular diseases are predicted for stroke (33.8% increase to 15 million) and heart failure (33.4% increase to 13 million), followed by ischemic heart disease (30.7% increase to 29 million) and heart attacks (16.9% increase to 16 million). Thus, an escalating prevalence of cardiovascular diseases (CVDs) is fueling advancement in the coronary stent market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Coronary Stents Market?
Key players in the coronary stent market, such as Abbott, are innovating their product offerings to lessen the frequency of repeat interventions, an issue common with bare-metal stents. They have introduced drug-eluting stents which strategically release medication over time as a measure to stop arteries from closing again - a condition known as restenosis. In a case in point, the XIENCE Sierra Everolimus Eluting Coronary Stent System was launched in India by Abbott, a well-known American healthcare organization, in May 2024. Distinctive attributes of this stent include its improved design, new delivery method, and customized size alternatives, all purposefully created to manage complex situations. Apart from these innovations, the stent maintains the drug-enveloped coating found on other XIENCE stents that decreases the chance of arterial obstruction. Furthermore, the stent comes with a commendable safety profile, backed by data gathered from over 120 clinical trials involving more than 120,000 patients.

How Is the Coronary Stents Market Segmented?
The coronary stents market covered in this report is segmented -

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents
2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies
3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum-Chromium, Nickel-Titanium, Polymer
4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents
5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:
1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents
2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents
3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents
4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents
5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents
6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents
7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents
8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents
9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp

Which Companies Are Leading the Charge in Coronary Stents Market Innovation?
Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation

Which Regions Are Leading the Global Coronary Stents Market in Revenue?
North America was the largest region in the coronary stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18325

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.